Cargando…
A possible asymmetry at the checkpoint
A recently published systematic review and meta-analysis indicated that anti-PD-1 treatment may confer superior survival outcomes as compared to anti-PD-L1. We propose mechanistic explanations supporting this finding.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330153/ https://www.ncbi.nlm.nih.gov/pubmed/32619818 http://dx.doi.org/10.1016/j.tranon.2020.100821 |